Daniel Malven
Managing Director @ 4490 Ventures
Chicago, United States
Daniel Malven is a Series A investor at 4490 Ventures in Chicago focused on Health Care and Software. Dan Malven offers a blend of venture capital investing, startup operational and corporate executive experience. He has been a co-founder of three VC-backed software companies, serving as the technical, code-writing founder of the first two, and the founding CEO of the third. He was also an executive in the consumer health services group ofWalgreens responsible for new digital health business lines. Dan was a Principal at NYC-based venture capital firm Flatiron Partners and has been investing in early-stage startups for over 20 years.Dan has a Masters of Business Administration from the Kellogg School of Management at Northwestern University and a Bachelor of Science in engineering from Purdue University. Dan is an alumnus of the Kauffman Fellows Program and a member of YPO.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Daniel Malven invests in
Stages Daniel Malven invests in
Countries Daniel Malven invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 5 (50%)
- Software 3 (30%)
- SaaS 2 (20%)
- FinTech 2 (20%)
- Medical 2 (20%)
Stage
- Series A 4 (40%)
- Series B 2 (20%)
- Seed 1 (10%)
- Funding Round 1 (10%)
- Venture - Series Unknown 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| QualSights is an immersive consumer insights platform that provides brands, agencies, and consulting firms the ability to generate deeper and more authentic insights from consumers anywhere in the world, in a dramatically faster and cost-effective way. Using proprietary technology, companies can remotely observe and interact with consumers as theyshop for, use or consume products in their natural environment. QualSights is the first and only truly integrated solution that seamlessly supports multiple research methodologies, blending the depth and authenticity of qualitative research with the speed and agility of quantitative research. Beyond its innovative data capture capabilities, QualSights’ platform offers a powerful suite of AI tools as well as an easy-to-use presentation builder that enables brands to analyze faster than ever before and quickly present compelling stories. | $7.7M / Series A / Nov 14, 2022 | ||
| Fluree is an open-source, blockchain-backed Data Management Platform for Web3 apps. Fluree empowers connected, trusted, and intelligent data ecosystems. Fluree is built on W3C semantic web standards in order to facilitate trusted data interoperability. | $13.1M / Seed / Sep 21, 2022 | ||
| Commercial buildings are responsible for 45% of all carbon emissions. Regulators and CRE investors are responding with penalties and investment strategies that could result in millions of dollars in fines and lost investments. This is why we have developed our machine-learning platform — the fastest, easiest, and most cost-effective path for youroffice buildings to increase asset value, reach your sustainability goals, and reduce operation costs, without needing to invest in expensive equipment or other capital expenditures. | $6M / Series A / May 12, 2021 | ||
| HealthBridge is an Insurtech company that unites all parties with a stake in healthcare payments. The company's mission is to reimagine the way the healthcare ecosystem addresses the growing financial burden of patient deductibles and coinsurance in the employer-sponsored insurance space. | $22M / Series B / May 11, 2021 | ||
| UPshow is the customizable engagement platform that capitalizes on businesses’ existing screens to deliver better audience experiences. UPshow’s technology seamlessly connects TV screens and mobile devices, creating a revolutionary in-venue network that drives customer and employee behaviors and maximizes profitability and efficiency. Founded in2015, UPshow reaches audiences on screens around the world. | $8M / Series A / Jun 17, 2020 | ||
| Fluree is an open-source, blockchain-backed Data Management Platform for Web3 apps. Fluree empowers connected, trusted, and intelligent data ecosystems. Fluree is built on W3C semantic web standards in order to facilitate trusted data interoperability. | $4.7M / Seed / Jun 03, 2019 | ||
| SwervePay develops payment solutions for the healthcare and auto service industries. The company’s products include a patient payment platform that integrates into an EHR in real-time and allows patients payments with no app to download or portal to log into; and a solution named “SwervePay Auto” designed to streamline the payment cycle from startto finish in the auto service industry. | Venture - Series Unknown / Jan 01, 2018 | ||
| Level Ex is a developer of professional medical video games designed for physicians to capture the challenges of practicing medicine. They use video game technology and cognitive neuroscience to capture the challenges of practicing medicine, allowing physicians to keep up-to-speed on rare and challenging cases, new medical devices, and drugtherapies. | $11M / Series A / Oct 03, 2017 | ||
| physIQ has developed a personalized physiology analytic platform (PPA) for use in both the regulated healthcare market as well as the unregulated health and fitness market. The technology is designed to detect subtle changes in vital signs and other health indicators to help clinicians manage patients with chronic illness, and to help consumerstrack their own health and fitness levels. The key differentiator between the physIQ platform and other technologies is that it constructs a personalized baseline norm for each person monitored, rather than simple trending or comparison to population-based statistics. Our technology can also be embedded into patient monitoring devices from other manufacturers who are seeking to design "smarter" products. | $8M / Series B / Jul 25, 2017 | ||
| Retrofit is the weight loss company that bridges the gap between what you know and what you do.With a science based, tech-enabled, proven approach, delivered with the human touch of multi-disciplinary certified wellness experts, Retrofit makes you aware and conscious of your relationship with food, so you can overcome barriers to healthyeating, and improve your attitudes towards physical activity.We know that you are highly informed about eating nutritious foods and very knowledgeable about how to maximize physical activity, but let’s face it, we all have lots of reasons for not doing either.We are honored to have some of the nation's leading experts in weight management build the Retrofit program from sound medical research and clinical data to serve the needs of real people. | $2.7M / Mar 15, 2012 |
Co-Investors
About 4490 Ventures
4490 Ventures is a technology-focused, early-stage venture capital fund based in Madison, Wisconsin. The fund seeks to invest in companies in the Midwest. It seeks to invest between $5 million to $8 million per investment.
4490 Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Daniel Malven
Managing Director
|
|||
Greg Robinson
Managing Director
|
|||
Malcolm Thorne
Managing Director
|
|||
Gian Fulgoni
Venture Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Daniel Malven invest in?
Daniel Malven invests primarily in Health Care, Software and SaaS startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Daniel Malven?
Public channels for Daniel Malven include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Daniel Malven last invest?
The most recent investment recorded for Daniel Malven closed in Nov 2022. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
